DailyIQ
|
Sector:HealthcareAll sectors
Last updated 24 minutes ago

NTRA·NTRA

$.
-. (-.%)
After Hours
High
$213.30
Open
$208.83
Market Cap
28.53B
52W High
$256.36
Low
$204.04
P. Close
$197.59
P/E
-
52W Low
$125.38
Fwd P/E
-
Mean Target
-
Technical Score (1D)
27
SELL
News Sentiment
-
NO DATA
Okay, I'm ready to craft the "What's happening today and why?" section for NTRA, adhering to all the rules. Please provide the JSON list of articles. I will prioritize recent developments, maintain a trader-facing tone, and focus on actionable insights.
Earnings Summary
Natera, Inc. is a diagnostics company providing molecular testing services worldwide, operating within the Healthcare sector. The company's products include prenatal tests, cancer screening tests, and tests for various genetic conditions. The provided data only includes one quarter of earnings. In Q4 2024, the company reported an EPS of -0.41, missing the estimated -0.34659, with a revenue of 476061000.0. Not enough information is available to analyze historical trends or patterns. Recent news indicates that Natera initiated the EDEN study to assess early risk for preeclampsia and other adverse pregnancy outcomes, evaluating a non-invasive prenatal screening test. This study, enrolling up to 7,500 pregnant participants, could provide earlier detection methods. Investors should watch for updates on enrollment progress and preliminary study findings, which could influence market sentiment towards companies offering similar diagnostic solutions.

EPS

EstBeatMiss
$-0.42$-0.40$-0.38$-0.36$-0.34Q4'24
QtrEstActual+/−
Q4'24$-0.35$-0.41-18.3%

Revenue

EstBeatMiss
$476M$476M$476M$476M$476MQ4'24
QtrEstActual+/−
Q4'24 - $476M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

NTRA Stock Snapshot

NTRA is currently trading at $201.79, giving NTRA a market cap of 28.53B. Today's range spans $204.04–$213.30, with shares opening at $208.83 and moving up $4.20 (2.1%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL).

Over the past year NTRA has traded between $125.38 and $256.36 - the current price is +60.9% off the 52-week low and -21.3% from the high.

NTRA is showing a SELL signal (27/100) with neutral sentiment (-/100). Price: $201.79 (in the middle of its 52-week range within $125.38–$256.36). At 28.53B in Healthcare market cap, a bearish technical read accompanied by negative sentiment often marks the beginning of an earnings revision cycle downward - active managers trim before the revisions become consensus, compounding the selling pressure.

When a large-cap Healthcare name with 28.53B in capitalization prints a SELL signal (27/100) alongside neutral news sentiment (-/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $201.79 (in the middle of its 52-week range in the $125.38–$256.36 range), the structural support levels are where that sponsorship question gets answered.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…